Epstein Secrets

has "agreed to plead guilty to misleading the Drug Enforcement Administration in ways that resulted in otherwise- impermissible amounts of its drug" OxyContin "reaching the market, and to paying doctors and EFTA00135817 others kickbacks for helping increase sales." The company will pay "$8.3 billion wort

tment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

has "agreed to plead guilty to misleading the Drug Enforcement Administration in ways that resulted in otherwise-impermissible amounts of its drug" OxyContin "reaching the market, and to paying doctors and others kickbacks for helping increase sales." The company will pay "$8.3 billion worth of fines and

tment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

has "agreed to plead guilty to misleading the Drug Enforcement Administration in ways that resulted in otherwise- impermissible amounts of its drug" OxyContin "reaching the market, and to paying doctors and others kickbacks for helping increase sales." The company will pay "$8.3 billion worth of fines and

stment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.